Concepedia

Publication | Open Access

Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia

DOIFull Paper Access

66

Citations

26

References

2019

Year

Gang Heng, Jiankun Jia, Shiqi Li, Gang Fu, Meiling Wang, Dabing Qin, Yunyan Li, Pei Li, Xiaobo Tian, Jiasi Zhang,
Clinical Cancer Research

Abstract

T cells expressing the humanized anti-CD19 scFv CARs exhibited sustained therapeutic efficacy in the treatment of r/r ALL. Low replase rate was associated with the long-term persistence of CAR T cells.

References

YearCitations

Page 1